Parisi Gray Wealth Management’s AstraZeneca AZN Stock Holding History

Parisi Gray Wealth Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-621	Closed	-$74K	–	170
2021 Q2	$74K	Buy	+621	New	+$68.1K	0.03%	257
2019 Q2	–	Sell	-79	Closed	-$6K	–	143
2019 Q1	$6K	Hold	79	–	–	﹤0.01%	426
2018 Q4	$6K	Hold	79	–	–	﹤0.01%	441
2018 Q3	$6K	Hold	79	–	–	﹤0.01%	459
2018 Q2	$6K	Sell	79 -16	-17%	-$1.15K	﹤0.01%	468
2018 Q1	$7K	Sell	95 -59	-38%	-$4.09K	0.01%	464
2017 Q4	$11K	Buy	+154	New	+$10.4K	0.01%	433

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Parisi Gray Wealth Management's AZN Position: Q3 2021 in Review

Parisi Gray Wealth Management sold out of AstraZeneca (AZN) in Q3 2021, closing a stake of 621 shares — an estimated $74K sold.

Parisi Gray Wealth Management first reported a position in AZN in Q4 2017 and held it in 7 quarters. The position peaked at $74K in Q2 2021. 908 funds tracked by Wall St. Rank hold AZN as of Q3 2021.

Parisi Gray Wealth Management reported no remaining AstraZeneca position as of Q3 2021 after selling out during the quarter.
Parisi Gray Wealth Management sold 621 AstraZeneca shares in Q3 2021, an estimated $74K.
Parisi Gray Wealth Management first reported a position in AstraZeneca in Q4 2017 and held it in 7 quarters.
Parisi Gray Wealth Management's AstraZeneca position peaked at $74K in Q2 2021.
908 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2021.

Based on Parisi Gray Wealth Management's 13F filing for Q3 2021, filed 16 Nov 2021.